Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (FY)Jun 30, 2025 | (Q4)Jun 30, 2025 | (Q3)Dec 31, 2024 | (Q2)Sep 30, 2024 | (Q1)Jun 30, 2024 | (FY)Mar 31, 2024 | (Q4)Mar 31, 2024 | (Q3)Dec 31, 2023 | (Q2)Sep 30, 2023 | (Q1)Jun 30, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | -24.18%88.07M | -31.25%17.5M | -49.69%19.51M | -40.65%15.96M | -28.83%17.81M | -0.07%116.15M | 7.74%25.46M | -4.05%38.78M | 28.66%26.88M | -20.00%25.02M |
| Cost of revenue | -38.63%37.36M | -44.18%6.48M | -67.17%8.59M | -21.99%7.84M | -39.32%7.92M | -17.48%60.87M | -39.24%11.61M | 37.95%26.17M | -45.63%10.05M | -35.57%13.05M |
| Gross profit | -8.27%50.71M | -20.43%11.02M | -13.40%10.92M | -51.78%8.12M | -17.41%9.89M | 30.20%55.28M | 205.96%13.85M | -41.21%12.61M | 597.10%16.84M | 8.58%11.98M |
| Operating expense | -77.52%61.43M | -94.37%11.93M | -43.47%14.16M | -11.16%14.88M | -44.17%10.95M | 203.40%273.32M | 633.88%211.91M | -0.85%25.05M | -15.77%16.75M | 22.11%19.62M |
| Staff costs | ---- | ---- | ---- | ---- | ---- | -23.95%19.63M | ---- | ---- | ---- | ---- |
| Depreciation and amortization | ---- | ---- | ---- | ---- | ---- | -20.86%30.74M | ---- | ---- | ---- | ---- |
| -Depreciation | ---- | ---- | ---- | ---- | ---- | -20.86%30.74M | ---- | ---- | ---- | ---- |
| Other operating expenses | -78.43%61.43M | -94.66%11.93M | -43.47%14.16M | -11.16%14.88M | -44.17%10.95M | 532.98%284.84M | 1,478.08%223.42M | -0.85%25.05M | -15.77%16.75M | 22.11%19.62M |
| Total other operating income | ---- | ---- | ---- | ---- | ---- | 216.31%61.88M | ---- | ---- | ---- | ---- |
| Operating profit | 95.08%-10.73M | 99.54%-910K | 73.95%-3.24M | -8,249.40%-6.76M | 86.14%-1.06M | -357.77%-218.05M | -713.47%-198.06M | -226.17%-12.44M | 100.48%83K | -51.76%-7.64M |
| Net non-operating interest income (expenses) | 21.84%-14.1M | 19.02%-2.66M | 24.10%-3.68M | 14.28%-4.01M | 19.53%-4.21M | 11.45%-18.04M | 2.17%-3.28M | 19.49%-4.84M | 18.23%-4.68M | 0.85%-5.23M |
| Non-operating interest expense | -20.14%14.1M | -8.30%2.66M | -24.10%3.68M | -14.28%4.01M | -19.53%4.21M | -11.33%17.65M | 0.10%2.9M | -19.49%4.84M | -18.23%4.68M | -0.85%5.23M |
| Total other finance cost | ---- | ---- | ---- | ---- | ---- | -16.50%383.83K | ---- | ---- | ---- | ---- |
| Net investment income | ||||||||||
| Gain(Loss) on financial instruments designated as cash flow hedges | ||||||||||
| Gain(Loss) on derecognition of available-for-sale financial assets | ||||||||||
| Income from associates and other participating interests | 75.37%-4.49M | 101.77%184K | 99.75%-19K | -52.73%-2.12M | -321.13%-2.39M | -352.38%-18.22M | -374.11%-10.39M | -447.37%-7.52M | -163.79%-1.39M | 217.92%1.08M |
| Special income (charges) | -154.98%-1.96M | |||||||||
| Less:Write off | ---- | ---- | ---- | ---- | ---- | 154.98%1.96M | ---- | ---- | ---- | ---- |
| Other non-operating income (expenses) | 8.02M | 3.6M | -80.25%1.51M | 187.37%2.55M | -94.69%364K | 354.93%7.66M | -99.53%887K | 921.31%6.85M | ||
| Income before tax | 91.69%-21.3M | 100.09%217K | 68.36%-5.42M | -102.98%-10.35M | -47.64%-7.29M | -316.33%-256.27M | -5.77%-229.09M | -186.59%-17.14M | -103.02%-5.1M | 53.21%-4.94M |
| Income tax | -92.65%110K | 0 | -99.50%1K | -90.55%38K | -66.03%71K | 72.17%1.5M | -33.38%687.24K | 222.84%199K | 402K | 209K |
| Net income | 91.70%-21.41M | 100.09%217K | 68.72%-5.42M | -88.84%-10.39M | -43.03%-7.36M | -299.68%-257.76M | -602.77%-229.78M | -197.99%-17.33M | -103.27%-5.5M | -675.30%-5.15M |
| Net income continuous operations | 91.70%-21.41M | 100.09%217K | 68.72%-5.42M | -88.84%-10.39M | -43.03%-7.36M | -312.93%-257.76M | -5.59%-229.78M | -197.99%-17.33M | -103.26%-5.5M | 51.23%-5.15M |
| Net income discontinuous operations | ---- | ---- | ---- | ---- | --0 | --0 | ---- | ---- | ---- | --0 |
| Noncontrolling interests | 140.35%989K | 108.59%239K | 400.82%734K | -292.59%-936K | -62.22%34K | -195.13%-2.45M | -130.15%-2.78M | -217.87%-244K | 69.34%486K | -97.27%90K |
| Net income attributable to the company | 91.23%-22.4M | 99.99%-22K | 63.98%-6.16M | -57.87%-9.45M | -41.22%-7.4M | -301.81%-255.31M | -620.92%-227M | -183.70%-17.09M | -103.56%-5.99M | -32.41%-5.24M |
| Preferred stock dividends | ||||||||||
| Other under preferred stock dividend | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net income attributable to common stockholders | 91.23%-22.4M | 99.99%-22K | 63.98%-6.16M | -57.87%-9.45M | -41.22%-7.4M | -301.81%-255.31M | -620.92%-227M | -183.70%-17.09M | -103.56%-5.99M | -32.41%-5.24M |
| Gross dividend payment | ||||||||||
| Basic earnings per share | ||||||||||
| Diluted earnings per share | ||||||||||
| Dividend per share | ||||||||||
| Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.